Posted by denise528 on April 24, 2003, at 10:29:19
Hi,
I was reading the following on the neurocrine site.
NBI-34041 for Anxiety and Depression: Completed Phase I single dose and multiple dosestudies with the CRF1 receptor antagonist. Tolerability and pharmacokinetic properties were
demonstrated. Further Phase I studies are planned for 2002 and Phase II clinical trials in
patients with anxiety and depression are expected to start late 2002 or early 2003.Does anyone know anything about how these trials are going or how a person could go about getting onto one of these trials?
Denise
poster:denise528
thread:221973
URL: http://www.dr-bob.org/babble/20030423/msgs/221973.html